Cases of human metapneumovirus, or HMPV, are on the rise in parts of California. It typically causes mild, cold-like symptoms ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. You’re listening to our weekly science news roundup. Let’s start off with a vaccine 180.

Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Jessica Mendoza: Liz, we're both here in DC, and I don't know about you, but I ...

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of-its-kind shot.

WICHITA, Kan. (KWCH) - This year’s flu season is not giving up, forcing some school districts around Kansas to close. Pharmacists in Wichita say they continue to see high numbers of flu patients.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The compromise clears a path for ...

As Illinois experiences its most severe flu season in over a decade, public health officials report rising hospitalizations and lower vaccination rates across the state. Influenza spreads year after ...

The Food and Drug Administration’s recent decision to turn away Moderna’s application for a new flu shot for older Americans is a troubling development in health officials’ piecemeal dismantling of ...

The Food and Drug Administration has refused to review an application from the biotech company Moderna to approve its mRNA-based flu vaccine. Javascript is required ...

Moderna Inc.’s shares plunged after U.S. regulators refused to review its novel mRNA flu vaccine, dealing a major blow to the company as it seeks more products beyond its COVID shot. The U.S. Food and ...

Update: The FDA reversed its decision on Feb. 18 and agreed to consider Moderna's application. Read the latest here. Our earlier story is below. The Food and Drug Administration is refusing to ...